The U.K. Authorizes AstraZeneca’s Coronavirus Vaccine for Emergency Supply

1 min read

On Wednesday morning, the U.K. authorized AstraZeneca‘s (NASDAQ: AZN) coronavirus vaccine candidate for emergency supply. The first doses of COVID-19 Vaccine AstraZeneca (formerly known as AZD1222) will be released today with the intention to begin vaccinations early in the new year.

The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) recommends two full doses given four to 12 weeks apart. This is the dosing regimen that appeared 62% effective in clinical trials in the U.K. and Brazil.

Images source: Getty Images.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

Pinterest Stock Has Surged 270% So Far in 2020: Is It a Buy for 2021?

Next Story

Why AMC Entertainment Is Falling 6% Today

Latest from Blog